Cone Neurosurgical Research Laboratory, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, Canada H3A 2B4.
Brain Res Bull. 2012 Jan 4;87(1):44-9. doi: 10.1016/j.brainresbull.2011.10.009. Epub 2011 Oct 25.
The effects of the administration of the serotonin (5-HT)(2A) antagonist, M100907, on 5-HT synthesis rates, were evaluated using the α-[(14)C]methyl-l-tryptophan (α-MTrp) autoradiographic method. In the treatment study, M100907 (10mg/kg) was injected intraperitoneally 30 min before the α-MTrp injection (30 μCi over 2 min). A single dose of M100907 caused a significant decrease in the synthesis in the anterior olfactory nucleus, accumbens nucleus, frontal cortex, sensory-motor cortex, cingulate cortex, medial caudate-putamen, dorsal thalamus, substantia nigra, inferior collicus, raphe magnus nucleus, superior olive, and raphe pallidus nucleus. These data suggest that the terminal 5-HT(2A) receptors are involved in the regulation of 5-HT synthesis in the entire brain. Further, 5-HT synthesis is likely regulated by the 5-HT(2A) antagonistic property of M100907 in the cortices, anterior olfactory nucleus, caudate putamen, and nucleus accumbens.
采用α-[(14)C]甲基-l-色氨酸(α-MTrp)放射自显影法评估了 5-羟色胺(5-HT)(2A)拮抗剂 M100907 对 5-HT 合成率的影响。在治疗研究中,M100907(10mg/kg)在α-MTrp 注射前 30 分钟(2 分钟内 30μCi)腹腔内注射。单次给予 M100907 可显著降低前嗅核、伏隔核、额叶皮质、感觉运动皮质、扣带回皮质、内侧尾壳核、背侧丘脑、黑质、下丘、中缝大核、上橄榄核和苍白球核的合成。这些数据表明,终端 5-HT(2A)受体参与了整个大脑中 5-HT 合成的调节。此外,5-HT 的合成可能受到 M100907 在皮质、前嗅核、尾壳核和伏隔核中的 5-HT(2A)拮抗特性的调节。